在癌症进展过程中映射染色体外DNA放大
Hoon Kim1,2,3, Soyeon Kim4,5, Taylor Wade6
1Department of Biopharmaceutical Convergence, School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea. wisekh@skku.edu.
Nature genetics
|October 14, 2024
概括
外染色体DNA (ecDNA) 放大在晚期癌症中更为常见,可能有助于瘤对治疗作出反应. 这些遗传元素,即染色体外DNA (ecDNA),在癌症进展和转移过程中提供了竞争优势.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 外染色体DNA (ecDNA) 放大在癌症进展中起作用.
- 了解ecDNA的流行和特征对于癌症研究至关重要.
研究的目的:
- 研究染色体外DNA (ecDNA) 放大在癌症进展和治疗反应中的作用.
- 在各种癌症阶段检测和分类焦点放大.
主要方法:
- 分析了8060种原发性癌症,未经治疗的转移和预先治疗的瘤中的焦点放大.
- 对不同癌症阶段和治疗状态的ecDNA频率进行比较.
- 对匹配的瘤样本进行纵向分析,以评估ecDNA保留.
主要成果:
- 外染色体DNA (ecDNA) 放大在未经治疗的转移性和预先治疗的瘤中比新诊断的癌症更为频繁.
- 与未经治疗的癌症相比,化学疗法预治疗患者的瘤显示出更高的ecDNA频率.
- 染色体外DNA (ecDNA) 的增加与图林抑制有关,这表明它在治疗反应中发挥了作用.
- 在纵向样本中,ecDNAs更有可能被保留,而不是染色体放大.
- 晚期癌症中的ecDNA和在时间点之间共享的ecDNA显示出更局部的超突变事件,这表明早期的突变发生.
结论:
- 异染色体DNA (ecDNA) 放大在晚期癌症中很普遍,有助于瘤的进展和转移.
- 埃克DNA可能会给瘤带来竞争优势,影响它们对治疗的反应.
- 早期的ecDNA突变发生与癌症的发展有关.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


